Anti-GALNT13 antibody
Specifications
| Product Cat#: | AB-06-1835 |
| Product type: | Primary antibody |
| Antigen: | GALNT13 |
| Immunogen: | KLH conjugated synthetic peptide derived from human GALNT13/GalNAc-T13 351-450/556 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:500-1:2000) |
| Reactivity: | Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, Sheep |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| Alternative names: | GalNAc-T13 |
| GalNAc T13 | |
| GalNAc transferase 13 | |
| N acetylgalactosaminyltransferase 13 | |
| Polypeptide GalNAc transferase 13 | |
| pp GaNTase 13 | |
| Protein UDP acetylgalactosaminyltransferase 13 | |
| UDP GalNAc:polypeptide N acetylgalactosaminyltransferase 13 | |
| UDP N acetyl alpha D galactosamine:polypeptide |
Show More
Target information
Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Has a much stronger activity than GALNT1 to transfer GalNAc to mucin peptides, such as Muc5Ac and Muc7. Able to glycosylate SDC3. May be responsible for the synthesis of Tn antigen in neuronal cells.
Provider
Erpantech Laboratory
